Exploration on the Effects and Molecular Mechanisms of Pterostilbene on Esophageal Cancer Based on Network Pharmacology
DOI:
https://doi.org/10.53469/jcmp.2024.06(12).45Keywords:
Esophageal squamous cell carcinoma, Pterostilbene, Network pharmacologyAbstract
This study used a network pharmacology approach to analyze the potential role of Pterostilbene (PTS) in esophageal squamous cell carcinoma (ESCC). Compared with traditional ESCC treatments, which often have single targets, limited efficacy, and significant side effects, PTS, as a natural flavonoid compound, offers multiple targets, pathways, strong bioavailability, and blood-brain barrier penetration. These properties may compensate for the shortcomings of conventional drugs. The study constructed the PTS target network and PPI network, systematically analyzing its core targets and related pathways, providing a theoretical foundation for the development of PTS as a new drug for the prevention and treatment of ESCC.
References
QI L, SUN M, LIU W, et al. Global esophageal cancer epidemiology in 2022 and predictions for 2050: A comprehensive analysis and projections based on GLOBOCAN data [J]. Chin Med J (Engl), 2024.
ZHU H, WANG Z, DENG B, et al. Epidemiological landscape of esophageal cancer in Asia: Results from GLOBOCAN 2020 [J]. Thorac Cancer, 2023, 14(11): 992-1003.
WANG M, MIAO H. Disease burden and related risk factors of esophageal cancer in China and globally from 1990 to 2021, with forecast to 2035: An analysis and comparison [J]. Tob Induc Dis, 2024, 22.
MA Z, ZHANG X, XU L, et al. Pterostilbene: Mechanisms of its action as oncostatic agent in cell models and in vivo studies [J]. Pharmacol Res, 2019, 145: 104265.
ESTRELA J M, ORTEGA A, MENA S, et al. Pterostilbene: Biomedical applications [J]. Crit Rev Clin Lab Sci, 2013, 50(3): 65-78.
HUANG F L, YU S J. Esophageal cancer: Risk factors, genetic association, and treatment [J]. Asian J Surg, 2018, 41(3): 210-5.
CHEN X, CHENG G, ZHU L, et al. Alarmin S100A8 imparts chemoresistance of esophageal cancer by reprogramming cancer-associated fibroblasts [J]. Cell Rep Med, 2024, 5(6): 101576.
ZHU L, CHEN X, ZHU Y, et al. Dihydroartemisinin Inhibits the Proliferation of Esophageal Squamous Cell Carcinoma Partially by Targeting AKT1 and p70S6K [J]. Front Pharmacol, 2020, 11: 587470.
MA Z Q, FENG Y T, GUO K, et al. Melatonin inhibits ESCC tumor growth by mitigating the HDAC7/beta-catenin/c-Myc positive feedback loop and suppressing the USP10-maintained HDAC7 protein stability [J]. Mil Med Res, 2022, 9(1): 54.
YUAN H, ZHAO Z, XU J, et al. Hypoxia-induced TMTC3 expression in esophageal squamous cell carcinoma potentiates tumor angiogenesis through Rho GTPase/STAT3/VEGFA pathway [J]. J Exp Clin Cancer Res, 2023, 42(1): 249.
ZHANG X, WANG M, FENG J, et al. Multifunctional nanoparticles co-loaded with Adriamycin and MDR-targeting siRNAs for treatment of chemotherapy-resistant esophageal cancer [J]. J Nanobiotechnology, 2022, 20(1): 166.
GAO X, WANG Y, LU F, et al. Extracellular vesicles derived from oesophageal cancer containing P4HB promote muscle wasting via regulating PHGDH/Bcl-2/caspase-3 pathway [J]. J Extracell Vesicles, 2021, 10(5): e12060.
GUO D, JIN J, LIU J, et al. Baicalein Inhibits the Progression and Promotes Radiosensitivity of Esophageal Squamous Cell Carcinoma by Targeting HIF-1A [J]. Drug Des Devel Ther, 2022, 16: 2423-36.
LI Q, LUO H, DAI F Q, et al. SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating MYH9-Mediated GSK3beta/beta-Catenin Signaling [J]. Adv Sci (Weinh), 2023, 10(11): e2203573.
OYOSHI H, DU J, SAKAI S A, et al. Comprehensive single-cell analysis demonstrates radiotherapy-induced infiltration of macrophages expressing immunosuppressive genes into tumor in esophageal squamous cell carcinoma [J]. Sci Adv, 2023, 9(50): eadh9069.
TALUKDAR F R, DI PIETRO M, SECRIER M, et al. Molecular landscape of esophageal cancer: implications for early detection and personalized therapy [J]. Ann N Y Acad Sci, 2018, 1434(1): 342-59.
YANG Y, LI S, SHI W, et al. Pterostilbene suppresses the growth of esophageal squamous cell carcinoma by inhibiting glycolysis and PKM2/STAT3/c-MYC signaling pathway [J]. Int Immunopharmacol, 2024, 142(Pt B): 113247.
FENG Y, YANG Y, FAN C, et al. Pterostilbene Inhibits the Growth of Human Esophageal Cancer Cells by Regulating Endoplasmic Reticulum Stress [J]. Cell Physiol Biochem, 2016, 38(3): 1226-44.
HSEU Y C, VUDHYA GOWRISANKAR Y, WANG L W, et al. The in vitro and in vivo depigmenting activity of pterostilbene through induction of autophagy in melanocytes and inhibition of UVA-irradiated alpha-MSH in keratinocytes via Nrf2-mediated antioxidant pathways [J]. Redox Biol, 2021, 44: 102007.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Guanglin Liu, Xiaolong Yan, Jialing Jiang
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
